Search Results - "Yue, Huiran"
-
1
Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer
Published in Gynecologic oncology (01-02-2021)“…Periostin (POSTN) overexpression observed in various cancer types is correlated with metastasis and tumor progression. However, its effect on the crosstalk…”
Get full text
Journal Article -
2
Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance
Published in Acta biochimica et biophysica Sinica (06-04-2023)“…Antiangiogenic therapies, such as treatment with bevacizumab, display modest survival benefits in ovarian cancer (OC) patients. After a transient response, the…”
Get full text
Journal Article -
3
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
Published in BMC cancer (30-12-2019)“…The clinical significance of hematogenous and lymphatic metastasis in ovarian cancer has been increasingly addressed, as it plays an imperative role in the…”
Get full text
Journal Article -
4
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
Published in Journal of translational medicine (21-01-2023)“…The overall survival rate of patients with advanced ovarian cancer (OC) has remained static for several decades. Advanced ovarian cancer is known for its poor…”
Get full text
Journal Article -
5
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
Published in BMC cancer (14-01-2021)“…The role of nicotinamide N-methyltransferase (NNMT) in ovarian cancer is still elusive. Our aim is to explore the expression of NNMT in ovarian cancer and to…”
Get full text
Journal Article -
6
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
Published in Cancer cell international (18-06-2020)“…Deregulation of integrins signaling had been documented to participate in multiple fundamental biological processes, and the aberrant expression of integrin…”
Get full text
Journal Article -
7
DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer
Published in Clinical epigenetics (01-12-2021)“…High-grade serous ovarian cancer (HGSOC) is the most common type of epigenetically heterogeneous ovarian cancer. Methylation typing has previously been used in…”
Get full text
Journal Article -
8
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
Published in Journal of ovarian research (21-05-2019)“…Our aim is to analyzed the expression pattern of sirtuin(SIRT) superfamily and evaluated their prognostic values in serous ovarian cancer patients. We first…”
Get full text
Journal Article -
9
Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression
Published in Journal of ovarian research (22-11-2021)“…Lymphovascular space invasion (LVSI) is the first step of hematogenous metastasis. Exploration of the differential miRNA expression profiles between…”
Get full text
Journal Article -
10
Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
Published in Acta biochimica et biophysica Sinica (06-04-2023)“…Antiangiogenic therapies, such as treatment with bevacizumab, display modest survival benefits in ovarian cancer (OC) patients. After a transient response, the…”
Get full text
Journal Article -
11
Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis
Published in European journal of obstetrics & gynecology and reproductive biology (01-07-2019)“…To enable a comparison of reported chemotherapy regimens in gestational trophoblastic neoplasia (GTN) patients with a International Federation of Gynecology…”
Get full text
Journal Article -
12
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/[beta]-catenin axis and acts as a therapeutic target in ovarian cancer
Published in Journal of translational medicine (21-01-2023)“…Background The overall survival rate of patients with advanced ovarian cancer (OC) has remained static for several decades. Advanced ovarian cancer is known…”
Get full text
Journal Article -
13
SNAI2 3'untranslated region promotes the invasion of ovarian cancer cells by inducing MARCKS expression
Published in Journal of Cancer (01-01-2019)“…: Recently, accumulating evidence has indicated that the 3' untranslated regions (3'UTRs) of protein coding genes play critical roles in the progression of…”
Get full text
Journal Article